Internet Explorer does not cooperate with this site. Please see below for options that work with APNA eLearning.*

2021-23: The Long Road Home: One Patient’s Journey through the Neurotherapeutics Department at McLean Hospital: From TMS, to ECT, to Ketamine

The different neurotherapeutic modalities of TMS, ECT, and ketamine have proved safe and effective as adjunct therapies for those with treatment-resistant depression. A case study detailing one patient’s experience with each modality and current research will be reviewed.

Presenters:  Paula Bolton, MS, CNP, ANP-BC; Jonathan Foley, BSN

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Understand the various neurotherapeutic treatment modalities available for patients with treatment resistant depression.

Keywords:  ECT, TMS, Ketamine Therapy

Nursing Continuing Professional Development:
0.75 contact hours (0.5 of which are in pharmacology).  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 37th Annual Conference
Lake Buena Vista, FL

Access to this course will end:  November 30, 2025

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.